Jushi Holdings (JUSHF) Cash from Operations Growth (1y) (2022 - 2026)
Jushi Holdings (JUSHF) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.06 Bn | 20.90 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.62 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.81 Bn | 16.49 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 425.00% |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 14.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.38% |
| Dec 31, 2025 | -15.42% |
| Sep 30, 2025 | 156.11% |
| Jun 30, 2025 | -134.88% |
| Mar 31, 2025 | 15.96% |
| Dec 31, 2024 | 58.66% |
| Sep 30, 2024 | -3.42% |
| Jun 30, 2024 | 182.65% |
| Mar 31, 2024 | 281.77% |
| Dec 31, 2023 | -5.73% |
| Sep 30, 2023 | 603.69% |
| Jun 30, 2023 | 43.52% |
| Mar 31, 2023 | 74.16% |
| Dec 31, 2022 | -49.53% |
| Sep 30, 2022 | 95.41% |